PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: People
The Most Influential Pharma Leader Or Institution?
Ahead of Pharm Exec’s 30th Anniversary Issue later this year, we are assembling a list of pharma leaders who have made the most impact on the industry.
Which individual(s) or institution(s) do you think has had the most influence of the industry in the last 10–30 years?
Please leave a comment in the box below or drop [...]
New Roster of Players to Debate Comparative Effectiveness Standards
Methodologies are the heart of any consistent approach to certifying comparative effectiveness for new medicines—semantics aside, it’s the way payers and providers are going to determine clinical “value” and, by subtle extrapolation, their cost against existing alternative therapies. Last week, the Patient Centered Outcomes Research Institute [PCORI] created through federal health reform legislation moved one [...]
Also posted in Regulatory, healthcare, pricing Tagged comparative effectiveness, health care economics, PCORI, QALY Leave a comment
Former EMA Head Back in the Regulatory Saddle
His decade-long tenure as head of the European Medicines Agency (EMA) may have ended, but Thomas Lönngren is already back in the regulatory saddle as a strategic advisor to NDA Group, an independent consulting group focused on reducing wasted drug development costs, ensuring new medicines get to market faster, and “improving the performance of the [...]
Also posted in Europe, Global, Market Access, R&D, Regulatory, leadership, pricing Tagged EMA, Market Access, Regulatory, Strategy, Thomas Lönngren Leave a comment
Exclusive Interview: The European Medicine Agency's Thomas Lönngren
The European Medicines Agency (EMA) is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs. In return, EMA has made a virtue of necessity. It filled the regulatory [...]
Also posted in Europe, Global, Regulatory, leadership Tagged EMA, EU, European Medicines Agency, Regulatory, Thomas Lönngren 2 Comments
The Most Influential Pharma Leader Or Institution?